Maximum effectiveness, minimal side effects, least-possible damage to healthy tissue. Scientists have long pursued cancer treatment offering one or more of these benefits, and a researcher at the University of Tennessee at Chattanooga is now among them. Michael Danquah is researching a highly precise form of treatment delivery—at the nanoscale, molecular level—to fight leukemia. Danquah…
UTC research highlighted on national physical therapy website
Research from UTC is now on the website of the American Physical Therapy Association.
UTC professors give presentations at national symposium
Three professors from UTC took part recently in a national conference by the U.S. Public Health Service.